Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease

NCT02151643 is registered in ClinicalTrials.gov with Phosphate Therapeutics as lead sponsor.

NCT NCT02151643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02151643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Lead sponsor
Phosphate Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
May 7, 2014
Completion date
March 18, 2015
Enrollment
153 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hyperphosphataemia